ZA200606268B - Treatment of coronary or peripheral ischemia - Google Patents

Treatment of coronary or peripheral ischemia

Info

Publication number
ZA200606268B
ZA200606268B ZA200606268A ZA200606268A ZA200606268B ZA 200606268 B ZA200606268 B ZA 200606268B ZA 200606268 A ZA200606268 A ZA 200606268A ZA 200606268 A ZA200606268 A ZA 200606268A ZA 200606268 B ZA200606268 B ZA 200606268B
Authority
ZA
South Africa
Prior art keywords
coronary
treatment
peripheral ischemia
ischemia
peripheral
Prior art date
Application number
ZA200606268A
Other languages
English (en)
Inventor
Uzan Andre
Caron Alexis
Original Assignee
Aventis Pharma Sa
Centelion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Centelion filed Critical Aventis Pharma Sa
Publication of ZA200606268B publication Critical patent/ZA200606268B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200606268A 2003-12-29 2006-07-28 Treatment of coronary or peripheral ischemia ZA200606268B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53299303P 2003-12-29 2003-12-29

Publications (1)

Publication Number Publication Date
ZA200606268B true ZA200606268B (en) 2008-04-30

Family

ID=34738851

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606268A ZA200606268B (en) 2003-12-29 2006-07-28 Treatment of coronary or peripheral ischemia

Country Status (8)

Country Link
EP (1) EP1699819A2 (fr)
JP (1) JP2007536909A (fr)
KR (1) KR20070006714A (fr)
AU (1) AU2004309090A1 (fr)
CA (1) CA2550727A1 (fr)
MX (1) MXPA06007519A (fr)
WO (1) WO2005063807A2 (fr)
ZA (1) ZA200606268B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2700613C (fr) * 2007-09-26 2022-09-20 Celgene Cellular Therapeutics Cellules angiogeniques provenant d'un perfusat placentaire humain
WO2011130729A2 (fr) * 2010-04-16 2011-10-20 Salk Institute For Biological Studies Procédés de traitement de troubles métaboliques utilisant le fgf
WO2015061331A1 (fr) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Peptides de facteur de croissance des fibroblastes (fgf) 2/fgf1 chimériques et procédés d'utilisation
AU2014340241B2 (en) 2013-10-21 2018-11-01 Salk Institute For Biological Studies Mutated fibroblast growth factor (FGF) 1 and methods of use
EP3368059A4 (fr) 2015-10-30 2019-03-27 Salk Institute for Biological Studies Traitement de l'hyperglycémie induite par des stéroïdes avec des analogues de facteur de croissance des fibroblastes (fgf) 1
JP7333919B2 (ja) * 2017-09-05 2023-08-28 エクセル メッド、エルエルシー 虚血を治療するためのヘパリン組成物
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008828A1 (fr) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Traitements de lesions neuronales liees a l'ischemie, a l'hypoxie ou a la degenerescence neuronale
EP1283268A3 (fr) * 1996-08-23 2004-01-02 Ludwig Institute For Cancer Research Facteur recombinant de croissance de cellules vascularies endothéliales D (VEGF-D)
US6395707B1 (en) * 1997-02-14 2002-05-28 Genentech, Inc. Methods of treatment utilizing variants of vascular endothelial cell growth factor
US7252818B2 (en) * 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
IL133318A0 (en) * 1999-12-05 2001-04-30 Yeda Res & Dev Proteoglycans and pharmaceutical compositions comprising them
WO2003038054A2 (fr) * 2001-10-31 2003-05-08 New York University Conception et synthese de type structurel d'inhibiteurs de facteur de croissance fibroblastique (fgf), et composes modulateurs de fgf
EP1677831A1 (fr) * 2003-06-05 2006-07-12 Gencell S.A. Plasmide codant un facteur de croissance des fibroblastes pour le traitement de l'hypercholesterolemie ou du diabete associe a des anomalies angiogeniques

Also Published As

Publication number Publication date
JP2007536909A (ja) 2007-12-20
CA2550727A1 (fr) 2005-07-14
AU2004309090A1 (en) 2005-07-14
WO2005063807A2 (fr) 2005-07-14
EP1699819A2 (fr) 2006-09-13
MXPA06007519A (es) 2007-05-23
WO2005063807A3 (fr) 2005-09-29
KR20070006714A (ko) 2007-01-11

Similar Documents

Publication Publication Date Title
AU2003201651A8 (en) Surface treatment of industrial textiles
EP1689485A4 (fr) Traitement cardio-electromagnetique
AU2003212634A8 (en) Compounds useful in the treatment of cancer
GB0326486D0 (en) Combination treatment
GB0312407D0 (en) Treatment
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
GB0223570D0 (en) Surface treatment
ZA200606268B (en) Treatment of coronary or peripheral ischemia
AU2003258983A8 (en) Combinations for the treatment of fungal infections
IL177673A0 (en) Benzopyran compound useful for the treatment of arrhythmia
GB0221157D0 (en) Novel treatment
GB0223650D0 (en) Psoriasis treatment
GB0329416D0 (en) Treatment of cancer
IL176401A0 (en) Treatment of coronary or peripheral ischemia
GB0317500D0 (en) Treatment of bph
GB0327975D0 (en) Methods of treatment
GB0316641D0 (en) Leather treatment
GB0203328D0 (en) Substrate treatment
GB0229986D0 (en) Treatment of materials
GB0311944D0 (en) Treatment of sars
AU2003272553A8 (en) Treatment of schizophrenia
GB0325957D0 (en) The treatment of pain
AU2003210347A1 (en) Cathepsin y for the treatment of pain
GB0118023D0 (en) Treatment of ischemia
GB0327242D0 (en) Treatment of textiles